Meet the Low-Cost ETF That Solves the Vanguard Morningstar Value ETF's Biggest Flaw. Here's Why It's a Magnificent Buy in September.

The article argues that Vanguard’s Morningstar U.S. Large Cap Value ETF (VTV, $188B net assets) uses an “all-or-nothing” classification that can leave investors with a value ETF that is effectively missing modern “hybrid” companies. It contrasts this with Vanguard’s Russell 1000 Value ETF (VONV), which uses a semi-annual split-weighting methodology, partially allocating mega-cap names like Amazon, Apple, and Microsoft to both growth and value. It highlights similar low costs (VTV 0.03% vs VONV 0.06%) while citing 67.9% total return over the past three years for VTV, suggesting limited immediate market-moving impact.

Analysis

The actionable takeaway is not that one ETF is “better,” but that the value factor is increasingly being rewritten as a quality-plus-megacap blend. That matters because assets tracking a modernized value definition can silently increase overlap with the same handful of AI-capex and platform winners that dominate growth benchmarks, making “diversification” less diversifying than allocators think. In a risk-off tape, that hidden duration/megacap exposure should reduce the defensive profile investors expect from a value sleeve.

Near term, there is little direct catalyst beyond allocator education and model-portfolio churn, so this is more of a positioning than a fundamental event trade. Over 1-3 months, the main opportunity is relative-performance dispersion between traditional value baskets and Russell-style blended baskets if markets continue to reward earnings durability and buyback-heavy megacaps. Over 6-18 months, the structural winner is likely the index provider that best captures passive flows by matching how PMs actually think about mature tech franchises.

The contrarian point: the market may be overpaying for the idea that a “more modern” value ETF is automatically superior. If rates back up or the AI complex de-rates, VONV could underperform because it is still carrying implicit growth beta inside its value wrapper, while VTV retains a cleaner tilt toward financials, healthcare, and cyclicals. The thesis is falsified if VTV starts consistently outperforming VONV in a growth-led tape or if Russell-style blending fails to gain meaningful flow share versus Morningstar-style segmentation.

Key Decisions for Investors

• Relative-value idea: long VONV / short VTV in equal dollars for a 3-6 month horizon if the market remains quality- and megacap-led. Risk/reward is favorable only if investors keep paying for blended factor exposure; exit if VTV outperforms VONV by ~5% or more over a quarter, which would signal a return to classic value leadership.
• Use VONV as the cleaner expression of 'value with embedded AI/platform exposure' rather than a pure value hedge. Best entry is on broad market pullbacks when megacaps are sold indiscriminately; the hidden overlap with AAPL/AMZN/MSFT can create faster recovery than traditional value funds.
• Do not chase VTV as a defensive allocation substitute if the goal is lower factor correlation. For institutions needing true style diversification, pair VTV exposure with a separate megacap/growth hedge rather than assuming VTV alone offsets tech concentration risk.
• Watch a potential flow beneficiary in LSEGY over 6-18 months: if Russell methodology keeps winning share in passive and advisor channels, index/licensing economics improve modestly. This is a slow-burn setup, not a catalyst trade; only act if there is evidence of benchmark migration or ETF asset-share gains.
• If you want to express a reversal in the embedded-growth premium, pair long XLF or a diversified financials basket against VONV. That trade works if rates rise and the market re-prices duration-sensitive megacaps lower, exposing VONV’s less-defensive profile versus its label.